FdaApplication

NDA 209606

Back to search

Identifiers

Properties

PropertyValue
applicant_nameBRISTOL MYERS SQUIBB
application_typeNDA
approval_date2017-08-01

Products (2)

ProductActive ingredientStrengthDosage form
IDHIFAENASIDENIB MESYLATEEQ 100MG BASETABLET;ORAL
IDHIFAENASIDENIB MESYLATEEQ 50MG BASETABLET;ORAL

2 products